Page last updated: 2024-08-17

adenosine diphosphate and Cardiomyopathy, Hypertrophic

adenosine diphosphate has been researched along with Cardiomyopathy, Hypertrophic in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's1 (12.50)18.2507
2000's1 (12.50)29.6817
2010's5 (62.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dai, Y; Fu, Y; Han, F; Huang, W; Kang, L; Li, D; Li, S; Liu, Z; Ma, Q; Pan, H; Qin, D; Shu, J; Song, Y; Sun, Y; Tan, C; Wang, X; Xu, C; Xu, X; Yan, Q; Yang, W; Zhang, X; Zhou, N; Zhu, X1
Bertero, E; Maack, C; Sequeira, V1
Bloemink, M; Combs, A; Deacon, J; Geeves, MA; Langer, S; Leinwand, L; Vera, C1
den Toom, ML; Szatmári, V; Teske, E; van Leeuwen, MW1
Hood, DA; Menzies, KJ; Robinson, BH1
Bookwalter, CS; Cheema, Y; Debold, EP; Saber, W; Trybus, KM; Vanburen, P; Warshaw, DM1
Bittner, RE; Gross, M; Marx, M; Skyllouriotis, ML; Skyllouriotis, P; Wimmer, M1
Fenchel, G; Hoffmeister, HE; Michel, J; Storf, R1

Reviews

1 review(s) available for adenosine diphosphate and Cardiomyopathy, Hypertrophic

ArticleYear
Energetic drain driving hypertrophic cardiomyopathy.
    FEBS letters, 2019, Volume: 593, Issue:13

    Topics: Adenosine Diphosphate; Animals; Cardiomyopathy, Hypertrophic; Energy Metabolism; Humans; Reactive Oxygen Species

2019

Trials

1 trial(s) available for adenosine diphosphate and Cardiomyopathy, Hypertrophic

ArticleYear
Effects of clopidogrel therapy on whole blood platelet aggregation, the Plateletworks® assay and coagulation parameters in cats with asymptomatic hypertrophic cardiomyopathy: a pilot study.
    The veterinary quarterly, 2017, Volume: 37, Issue:1

    Topics: Adenosine Diphosphate; Animals; Asymptomatic Diseases; Blood Coagulation; Cardiomyopathy, Hypertrophic; Cat Diseases; Cats; Clopidogrel; Double-Blind Method; Female; Male; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine

2017

Other Studies

6 other study(ies) available for adenosine diphosphate and Cardiomyopathy, Hypertrophic

ArticleYear
Mitochondrial Dysfunctions Contribute to Hypertrophic Cardiomyopathy in Patient iPSC-Derived Cardiomyocytes with MT-RNR2 Mutation.
    Stem cell reports, 2018, 03-13, Volume: 10, Issue:3

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Calcium; Cardiomyopathy, Hypertrophic; Electrophysiological Phenomena; Humans; Induced Pluripotent Stem Cells; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Proteins; Mutation; Myocytes, Cardiac; RNA, Ribosomal, 16S

2018
The hypertrophic cardiomyopathy myosin mutation R453C alters ATP binding and hydrolysis of human cardiac β-myosin.
    The Journal of biological chemistry, 2014, Feb-21, Volume: 289, Issue:8

    Topics: Actins; Adenosine Diphosphate; Adenosine Triphosphate; Amino Acid Substitution; Cardiac Myosins; Cardiomyopathy, Hypertrophic; Crystallography, X-Ray; Humans; Hydrolysis; Kinetics; Models, Molecular; Mutation; Myosin Heavy Chains; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary

2014
Effect of thyroid hormone on mitochondrial properties and oxidative stress in cells from patients with mtDNA defects.
    American journal of physiology. Cell physiology, 2009, Volume: 296, Issue:2

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Calcium; Cardiomyopathy, Hypertrophic; Case-Control Studies; Cell Line, Tumor; DNA-Binding Proteins; DNA, Mitochondrial; Electron Transport Complex I; Electron Transport Complex IV; Fibroblasts; Heat-Shock Proteins; Humans; Ion Channels; Leigh Disease; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Proteins; Mitochondrial Proton-Translocating ATPases; Mutation; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Reactive Oxygen Species; RNA, Transfer, Leu; Superoxide Dismutase; Thyroid Hormone Receptors alpha; Thyroid Hormone Receptors beta; Transcription Factors; Triiodothyronine; Uncoupling Protein 2

2009
Human actin mutations associated with hypertrophic and dilated cardiomyopathies demonstrate distinct thin filament regulatory properties in vitro.
    Journal of molecular and cellular cardiology, 2010, Volume: 48, Issue:2

    Topics: Actin Cytoskeleton; Actins; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cattle; Humans; Movement; Mutant Proteins; Mutation; Myosins; Protein Binding; Rabbits

2010
Myoadenylate deaminase deficiency, hypertrophic cardiomyopathy and gigantism syndrome.
    Pediatric neurology, 1997, Volume: 17, Issue:1

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; AMP Deaminase; Biopsy; Cardiomyopathy, Hypertrophic; Carnitine; Diagnosis, Differential; Gigantism; Humans; Inosine Monophosphate; Male; Muscle, Skeletal; Phenotype; Purine-Pyrimidine Metabolism, Inborn Errors

1997
Relationship between the high-energy phosphate content and various left ventricular functional parameters of the normal and hypertrophied heart after global ischemia and reperfusion.
    The Thoracic and cardiovascular surgeon, 1988, Volume: 36, Issue:2

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cardiomyopathy, Hypertrophic; Coronary Circulation; Energy Metabolism; Heart Arrest, Induced; Myocardial Contraction; Myocardium; Rats; Rats, Inbred SHR

1988